This implies that methylation-dependent transcriptional silencing is the mechanistic basis for the loss of mRNA expression, as is the case for a number of tumour suppressor genes in breast cancer, including p16INK4a, Rassf1a and E-cadherin among others. The gene discussed is RASSF1; the disease is breast carcinoma.